Comparison of Safety, Tolerability and Immunogenicity of Influenza Vaccines in Adults and Elderly
Clinical trial NCT00306527 · COMPLETED
Trial details
- NCT number
- NCT00306527
- Sponsor
- Novartis Vaccines
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-09-01
- Primary completion
- 2005-12-01
- Enrollment
- 2235
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.